X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16025) 16025
Publication (1154) 1154
Book Review (384) 384
Book Chapter (328) 328
Dissertation (25) 25
Conference Proceeding (21) 21
Book / eBook (17) 17
Magazine Article (14) 14
Web Resource (7) 7
Data Set (6) 6
Paper (4) 4
Journal / eJournal (2) 2
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antiepileptic drugs (10833) 10833
epilepsy (8771) 8771
humans (8047) 8047
index medicus (6493) 6493
clinical neurology (6439) 6439
male (5436) 5436
female (4943) 4943
anticonvulsants - therapeutic use (4519) 4519
seizures (4175) 4175
epilepsy - drug therapy (3602) 3602
animals (3385) 3385
adult (3282) 3282
pharmacology & pharmacy (3116) 3116
neurosciences (2934) 2934
anticonvulsants (2656) 2656
anticonvulsants - adverse effects (2493) 2493
neurology (2440) 2440
carbamazepine (2383) 2383
middle aged (2200) 2200
adolescent (2141) 2141
anticonvulsants - pharmacology (1944) 1944
psychiatry (1863) 1863
child (1742) 1742
children (1740) 1740
antiepileptic drug (1717) 1717
rats (1613) 1613
analysis (1610) 1610
lamotrigine (1591) 1591
antiepileptic agents (1495) 1495
mice (1418) 1418
treatment outcome (1401) 1401
aged (1368) 1368
valproic acid (1366) 1366
drugs (1351) 1351
dose-response relationship, drug (1342) 1342
pregnancy (1281) 1281
double-blind (1253) 1253
drug therapy (1220) 1220
phenytoin (1213) 1213
anticonvulsants - administration & dosage (1190) 1190
seizures - drug therapy (1137) 1137
young adult (1133) 1133
levetiracetam (1101) 1101
efficacy (1088) 1088
pharmacokinetics (1068) 1068
child, preschool (948) 948
temporal-lobe epilepsy (947) 947
topiramate (946) 946
anticonvulsants - pharmacokinetics (938) 938
risk factors (929) 929
drug interactions (886) 886
behavioral sciences (877) 877
retrospective studies (871) 871
disease models, animal (866) 866
pediatrics (833) 833
brain (820) 820
drug therapy, combination (816) 816
medicine & public health (809) 809
electroencephalography (801) 801
valproate (797) 797
status epilepticus (790) 790
therapy (780) 780
anticonvulsant (749) 749
care and treatment (742) 742
refractory epilepsy (718) 718
convulsions & seizures (704) 704
piracetam - analogs & derivatives (685) 685
seizure (677) 677
epilepsy - physiopathology (674) 674
gabapentin (648) 648
epilepsy - epidemiology (644) 644
anticonvulsants - blood (628) 628
monotherapy (617) 617
sodium valproate (612) 612
health aspects (604) 604
rats, wistar (594) 594
time factors (593) 593
infant (592) 592
oxcarbazepine (578) 578
risk (578) 578
valproic acid - therapeutic use (558) 558
epilepsies, partial - drug therapy (557) 557
carbamazepine - therapeutic use (548) 548
drug resistance (547) 547
adults (546) 546
chemistry, medicinal (536) 536
gaba (531) 531
women (531) 531
epilepsy - complications (529) 529
toxicology (526) 526
research (522) 522
partial-onset seizures (513) 513
patients (511) 511
fructose - analogs & derivatives (507) 507
surgery (506) 506
follow-up studies (496) 496
rats, sprague-dawley (487) 487
prospective studies (485) 485
clinical trials (478) 478
aged, 80 and over (466) 466
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15073) 15073
German (386) 386
Spanish (291) 291
French (213) 213
Russian (160) 160
Portuguese (68) 68
Japanese (56) 56
Czech (29) 29
Polish (23) 23
Chinese (20) 20
Hungarian (20) 20
Turkish (19) 19
Korean (17) 17
Italian (12) 12
Slovak (7) 7
Croatian (5) 5
Slovenian (4) 4
Arabic (2) 2
Azerbaijani (2) 2
Serbian (2) 2
Dutch (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Epilepsia, ISSN 0013-9580, 05/2010, Volume 51, Issue 5, pp. 797 - 804
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0161660
Journal Article
Journal Article
Neurochemical Research, ISSN 0364-3190, 7/2017, Volume 42, Issue 7, pp. 1873 - 1888
The identification of potential therapeutic agents for the treatment of epilepsy requires the use of seizure models. Except for some early treatments,... 
Neurochemistry | Biochemistry, general | Antiepileptic drug | Neurology | Neurosciences | Biomedicine | Fit-for-purpose models | Drug screening | Anticonvulsant screening project | Cell Biology | KAINATE-INDUCED EPILEPSY | TEMPORAL-LOBE EPILEPSY | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROSCIENCES | RAT MODEL | ABSENCE EPILEPSY | MURINE ENCEPHALOMYELITIS VIRUS | SPONTANEOUS MOTOR SEIZURES | ANTIEPILEPTIC DRUGS | SPONTANEOUS RECURRENT SEIZURES | RESISTANT PARTIAL EPILEPSY | LONG-TERM TREATMENT | Drug Evaluation, Preclinical - methods | Drug Resistant Epilepsy - diagnosis | Drug Evaluation, Preclinical - trends | Humans | Drug Discovery - trends | Seizures - drug therapy | Anticonvulsants - therapeutic use | Rats | Drug Discovery - methods | Seizures - diagnosis | Forecasting | Drug Resistant Epilepsy - drug therapy | Epilepsy - diagnosis | Animals | Epilepsy - drug therapy | Mice | Disease Models, Animal | Drugs | Anticonvulsants | Analysis | Epilepsy | Therapeutics | Drug discovery | Batteries | Seizures (Medicine) | Drug resistance | Homeopathy | Materia medica and therapeutics | Seizing | Therapy | Animal models | Stimulation | Pharmacology | Chemical compounds | Electrical stimuli | Convulsions & seizures | Phenobarbital | Rodents | Bromides | Sensitivity enhancement | Pentylenetetrazole | Phenytoin | Seizures | Lamotrigine
Journal Article
1995, 4th ed., ISBN 9780781702461, xxv, 1120
Book
1985, Handbook of experimental pharmacology, ISBN 9783540131083, Volume 74., xxii, 867
Book
1989, 3rd ed., ISBN 0881675393, xxvii, 1025
Book
1985, Handbook of experimental pharmacology, ISBN 9783540131083, Volume 74., xxii, 867
Book
1982, 2nd ed. --, ISBN 0890044988, xvii, 879
Book
2002, 5th ed., ISBN 0781723213, xv, 968
The thoroughly revised, updated Fifth Edition of this classic is the most comprehensive, current, and authoritative reference on all anticonvulsants available... 
Epilepsy -- Chemotherapy | Anticonvulsants | Chemotherapy | Epilepsy
Book
Epilepsy & Behavior, ISSN 1525-5050, 09/2019, Volume 98, Issue Pt A, pp. 201 - 206
We have previously shown that cannabidiol (CBD; Epidiolex®) significantly affects levels of clobazam/N-desmethylclobazam, rufinamide, topiramate, zonisamide,... 
Cannabidiol | Treatment-resistant epilepsy | Clobazam | Antiepileptic drugs | Drug interactions | PSYCHIATRY | TOPIRAMATE | CLINICAL NEUROLOGY | SEIZURES | SANAD | LAMOTRIGINE | RESISTANT EPILEPSY | BEHAVIORAL SCIENCES | MICE | INHIBITOR | CANNABINOIDS | Complications and side effects | Seizures (Medicine) | Epilepsy
Journal Article